Biological vs chemically induced hepatitis-A comparative study of oxidative stress parameters

Biomedical Research

Volumn 23, Issue 2, 2012, Pages 289-294

  Krishnamurthy, N ^a   Ghosh, Chinmoy ^a   Sumathi, M E ^a   Ashakiran, S ^a   Dayanand, C D ^a  

^a SRI DEVARAJ URS MEDICAL COLLEGE   (India)

Author keywords

Alcoholic Hepatitis; Ascorbic Acid; Glutathione(GSH); Hepatitis B virus infection; Malondialdehyde(MDA)

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CATALASE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ERYTHROCYTE; HEPATITIS B; HUMAN; HUMAN CELL; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; VITAMIN BLOOD LEVEL;

EID: 84860170617     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cheeseman KH, Slater TF. An Introduction to free radical biochemistry. BMB 1993; 49(3):481-493.
2. Sies H. Oxidants and antioxidants. Exp Physiol 1997; 82: 291-295.
3. Dufour DR. Liver disease. In: Burtis CA, Ashwood ER, Bruns DE. Teitz text book on clinical chemistry and molecular diagnostics. 4th edition, Singapore: Elsevier Inc;2006:1777-1847.
4. Ghany M, Hoofnagle JH. Approach to the patient with liver disease. In: Kasper, Braunwald, Fauci, Hauser, Lango, Jameson. Harrison's principles of internal medicine. 16th edition, United States of America: Mc Graw Hill; 2005:1808-1813.
5. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003;34:1-10.
6. Beutler E, Wesst C, Blume KG. Removal of leukocytes and platelets from whole blood. J Lab Cli Med 1976;88:328-333.
7. Liubuncic P, Tanne P, Bomzon A. Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut 2000;47:710-716.
8. Prakash M, Upadhya S, Prabhu R. Protein thiol oxidation and lipid peroxidation in patients with Uremia. Scand J Clin Invest 2004; 64: 599-604.
9. Sharmila U, Subramanya U, Mamatha K. Oxidantantioxidant status in colorectal cancer patients-before and after treatment. Indian Journal of Clinical Biochemistry 2004;19:80-83.
10. Das S.K, Vasudevan D.M. Monitoring oxidative stress in patients with non-alcoholic and alcoholic liver diseases. Indian Journal of Clinical Biochemistry 2005;20(2): 24-28.
11. Videla L.A, Iturriaga H, Pino M.E, Bunout D, Valenzuela A, Ugarate G. Content of hepatic reduced glutathione in chronic alcoholic patients: influence of the length of the absteinence and liver necrosis. Clin.Sci. 1984;66: 283-290.
12. Checa J.C.F, Hirano T, Tsukamoto H, Kaplowitz N. Mitochondrial glutathione deflection in alcoholic liver disease. Alcohol 1993;10:469-475.
13. Afiong A, Etim H, Maisie H, Etukudo Ascorbic acid levels in hepatitis and non-hepatitis subjects in university of Calabar Teaching Hospital (UCTH), Calabar. Pakistan Journal of Nutrition 2006;5(5):490-491.
14. Cheng J, Chen JM. Plasma superoxide dismutase measurement in children with viral hepatitis. Free Radic Res Commun. 1991;12-13:669-73.
15. Gath L, Macszaros I, Nameth H. Serum catalase enzyme activity in liver diseases. Acta Biol Hung. 1987;38(2):287-90.
16. Feinman L. Absorption and utilization of nutrients in alcoholism. Alcohol Health and Research World 1989;13(3):207-210.
17. Lieber CS. The influence of alcohol on nutritional status. Nutrition Reviews 1988;46(7):241-254.
18. Lieber CS. Alcohol and nutrition: An overview.Alcohol Health & Research World 1989;13(3):197-205.
19. Pratt DS, Kaplan MM. Evaluation of liver function. In: Kasper, Braunwald, Fauci, Hauser, Lango, Jameson. Harrison's principles of internal medicine. 16th edition, United States of America: Mc Graw Hill; 2005:1813-1816.
20. Dienstag JL, Isselbacher KJ. Acute viral hepatitis. In: Kasper, Braunwald, Fauci, Hauser, Lango, Jameson. Harrison's principles of internal medicine. 16th edition, United States of America: Mc Graw Hill; 2005:1822-1838.
21. Mailliard ME, Sorrell MF. Alcoholic liver disease. In: Kasper, Braunwald, Fauci, Hauser, Lango, Jameson. Harrison's principles of internal medicine. 16th edition, United States of America: Mc Graw Hill; 2005:1855-1858.
22. Colen JA, Kaplan MM. The SGOT/SGPT ratio an indication of alcoholic liver disease. Dig. Dis. Sci 1979;24:835-838.
23. Albano E, Tomasi A, Goria-Gatti L, Dianzani MU. Free radical metabolism of ethanol. In: Rice Evans C, ed. Free radicals, cell damage and disease. London: Richelieu Press,1986:117-126.
24. Waris G, Siddiqui A. Regulatory mechanisms of viral hepatitis B and C. J.Biosci.2003;28:311-321.
25. Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-κB via oxidative stress. Mol.Cell.Biol. 2001;21:7721-7730.
26. Rahmani Z, Huh KW, Lasher RL, Siddiqui A. Hepatitis B virus X protein colocalize to mitochondria with a human voltage-dependent anion channel,hVDAC3 and alters its transmembrane potential. J.Virol. 2000;74:2840-2846.